Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells


The Company
Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company developing novel oncology compounds that target cancer stem cells.
Pipeline
Cancer Stem Cells
Platform
Stemline Therapeutics has developed a Discovery Platform called StemScreen® to identify novel compounds that target and kill CSCs.


News
&
Events
7/28/2014
Stemline Announces Opening of SL-401 IND and Start of Trials in BPDCN and AML
6/10/2014
Stemline Therapeutics to Present at Wells Fargo Securities Healthcare Conference
5/28/2014
Stemline to Present at the Jefferies 2014 Global Healthcare Conference
Copyright 2014 - Stemline Therapeutics, Inc. All rights reserved
Stemline